{
     "PMID": "21129786",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20110517",
     "LR": "20121115",
     "IS": "1872-8421 (Electronic) 0165-5728 (Linking)",
     "VI": "232",
     "IP": "1-2",
     "DP": "2011 Mar",
     "TI": "Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestations.",
     "PG": "151-7",
     "LID": "10.1016/j.jneuroim.2010.11.001 [doi]",
     "AB": "To determine the effect of the tolerogenic peptide hCDR1 on hippocampal neurogenesis, we treated SLE-afflicted (NZBxNZW)F1 mice with hCDR1 (once a week for 10weeks). The treatment resulted in the up-regulation of neurogenesis in the dentate gyrus and restored the NeuN immunoreactivity in brain hippocampi of the mice in association with increased gene expression of IGF-1, NGF and BDNF. Furthermore, hCDR1 treatment significantly up-regulated p-ERK and p-Akt that are suggested to be key components in mediating growth factor-induced neurogenesis. The observed effects of hCDR1 on hippocampal-neurogenesis and on associated signaling pathways suggest a potential role for hCDR1 in CNS lupus.",
     "CI": [
          "Copyright (c) 2010 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Telerman, Alona",
          "Lapter, Smadar",
          "Sharabi, Amir",
          "Zinger, Heidy",
          "Mozes, Edna"
     ],
     "AU": [
          "Telerman A",
          "Lapter S",
          "Sharabi A",
          "Zinger H",
          "Mozes E"
     ],
     "AD": "Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20101203",
     "PL": "Netherlands",
     "TA": "J Neuroimmunol",
     "JT": "Journal of neuroimmunology",
     "JID": "8109498",
     "RN": [
          "0 (Antibodies, Monoclonal)",
          "0 (Nerve Growth Factors)",
          "0 (Peptide Fragments)",
          "38PLP07BKC (edratide)",
          "EC 2.7.- (Protein Kinases)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antibodies, Monoclonal/*therapeutic use",
          "Blotting, Western",
          "Disease Models, Animal",
          "Enzyme Activation/drug effects",
          "Female",
          "Gene Expression/drug effects",
          "Hippocampus/*drug effects/metabolism/pathology",
          "Humans",
          "Immunohistochemistry",
          "Lupus Vasculitis, Central Nervous System/*drug therapy/metabolism/pathology",
          "Mice",
          "Nerve Growth Factors/drug effects",
          "Neurogenesis/*drug effects",
          "Peptide Fragments/*therapeutic use",
          "Protein Kinases/drug effects",
          "Reverse Transcriptase Polymerase Chain Reaction",
          "Signal Transduction/drug effects"
     ],
     "EDAT": "2010/12/07 06:00",
     "MHDA": "2011/05/18 06:00",
     "CRDT": [
          "2010/12/07 06:00"
     ],
     "PHST": [
          "2010/08/31 00:00 [received]",
          "2010/10/28 00:00 [revised]",
          "2010/11/01 00:00 [accepted]",
          "2010/12/07 06:00 [entrez]",
          "2010/12/07 06:00 [pubmed]",
          "2011/05/18 06:00 [medline]"
     ],
     "AID": [
          "S0165-5728(10)00485-6 [pii]",
          "10.1016/j.jneuroim.2010.11.001 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Neuroimmunol. 2011 Mar;232(1-2):151-7. doi: 10.1016/j.jneuroim.2010.11.001. Epub 2010 Dec 3.",
     "term": "hippocampus"
}